How to Choose Human Serum — Off-the-Clot, Type AB, Male Donors
Five decisions determine which human serum fits your process. This guide works through each one, tells you when the more expensive option is genuinely necessary, and when it is not.
Which variant for which application?
Start here. If your application is listed, the recommendation column is the short answer.
| Application | Recommended | Why |
|---|---|---|
| MSC expansion, ATMP manufacturing | Off-the-clot Type AB — or hPL | No isoagglutinins, full growth factor profile |
| T-cell and CAR-T expansion | Type AB, off-the-clot preferred | Anti-A/anti-B would compromise the culture |
| PBMC isolation and culture | Type AB | Donor cells carry A/B antigens |
| Primary human cells, general | Type AB | Blood group of the cells is often unknown |
| Hormone-sensitive assays, endocrine research | Male donors | No hCG, no cycle-dependent variation |
| Lipid and lipoprotein studies | Delipidated serum | Endogenous lipids removed |
| Immunoassay matrix, diagnostics | Pooled standard serum | Representative human matrix; more on immunoassay use |
| Complement-dependent assays | Native, not heat inactivated | Heat treatment destroys the complement cascade |
| Routine established cell lines | Standard pooled serum | Type AB is usually unnecessary here |
| Autoimmune assay controls | Autoimmune control sera | Characterised for specific autoantibodies |
Decision 1 — Off-the-clot or plasma-derived?
What is the actual difference?
Off-the-clot (OTC) serum comes from whole blood that was allowed to clot naturally. The full coagulation cascade runs, platelets degranulate, and the growth factors they release — PDGF, TGF-β, EGF among them — end up in the serum.
Plasma-derived serum starts from plasma collected with an anticoagulant, usually citrate. Clotting is then induced artificially by adding calcium. The result is chemically similar but not identical: residual citrate and an altered ion balance are typical, and the growth factor profile differs because clotting did not follow its physiological course.
Decision 2 — Type AB or pooled?
It comes down to isoagglutinins
Blood group A donors carry anti-B antibodies, group B donors carry anti-A, and group O donors carry both. Only group AB donors carry neither. Pooled serum from mixed blood groups therefore contains isoagglutinins that can bind, agglutinate or lyse any cell carrying A or B antigens.
Most primary human cells do carry them. If you do not know the blood group of your cells — which is the normal case — Type AB removes the variable.
Decision 3 — Male donors or mixed?
Three reasons to specify male-only
- No hCG. Female donors may be pregnant without knowing. Human chorionic gonadotropin in the serum interferes with hormone assays and can affect hormone-responsive cells.
- Stable hormone profile. Oestradiol and progesterone vary across the menstrual cycle. Male-donor serum removes that batch-to-batch variability.
- Fewer HLA antibodies. Prior pregnancies induce anti-HLA antibodies. For some cell types, particularly immune cells, that is an unwanted variable.
Decision 4 — Heat inactivated or native?
Routine, but rarely questioned
Heat inactivation means 30 minutes at 56 °C. It destroys the complement cascade — and that is the only thing it reliably does. It also degrades heat-sensitive growth factors and some vitamins, so serum performance drops measurably in sensitive cultures.
Many laboratories heat inactivate every batch out of habit, carried over from protocols written for a different purpose decades ago.
Counterproductive when: you are running a complement-dependent assay, or culturing cells that depend on a full growth factor profile. If you are unsure, run one batch each way — the comparison is quicker than the debate.
Decision 5 — What documentation does your programme need?
The question that decides supplier, not product
For research use, standard donor screening is normally sufficient: HBsAg, HCV, HIV-1/2 and syphilis, with NAT testing where required.
For clinical and ATMP programmes the requirements are different in kind. You need documented country of origin, traceability back to the individual donation, consent documentation, and a supplier who can still deliver the same specification in three years.
Why EU origin is not a marketing line
Most human serum on the European market is collected in the United States.
For research that is unproblematic. For a European ATMP manufacturer who has to document a compliant supply chain, it is a real constraint — origin, consent framework and traceability all have to hold up under inspection, and a transatlantic chain adds steps that have to be evidenced.
SeamlessBio supplies human serum of European origin with the corresponding documentation, processed in Germany. If your programme needs that, say so with the enquiry and we will send the documentation set before you order.
The product range
Type AB, off-the-clot and male-donor variants are available in combination — tell us which attributes your process requires and we will confirm current availability.
Frequently asked questions
What does off-the-clot mean?
The serum was obtained from whole blood that clotted naturally, without an anticoagulant and without artificial recalcification. The coagulation cascade runs its physiological course, which affects the growth factor profile and leaves no residual citrate.
Why is Type AB human serum more expensive?
Only around four percent of European donors are blood group AB. Supply is structurally limited, and the serum is in demand precisely for the applications where alternatives do not work.
Can I use pooled serum instead of Type AB?
For established cell lines, usually yes. For primary human cells, PBMC and T-cell work, the isoagglutinins in pooled serum are a genuine risk — anti-A and anti-B can bind to cells carrying the corresponding antigens.
Do I have to heat inactivate human serum?
Only if complement activity interferes with your application. Heat inactivation also degrades growth factors, so it is not a free precaution. In complement-dependent assays it is actively wrong.
When do I need male-donor serum?
When hormones matter — endocrine research, hormone-sensitive assays, reproductive biology. The main reasons are absence of hCG and a hormone profile that does not vary with the menstrual cycle.
What is the difference between human serum and human platelet lysate?
hPL is produced from platelet concentrates and is markedly richer in growth factors. It has become the established xeno-free option for MSC expansion. Human serum is the broader-purpose product; hPL is the specialist for high-proliferation applications.
How is the serum screened?
Standard screening covers HBsAg, HCV, HIV-1/2 and syphilis, with NAT testing where required. Clinical programmes usually need more — ask for the full documentation set before ordering.
Can I reserve a lot?
Yes. For programmes that need the same specification over years, we hold a validated lot for you. See batch reservation.
Is a free test sample available?
Yes, on request. For serum, testing your own cells against a specific lot before committing is the only reliable form of qualification.
Are you already supplied by someone else?
Switching supplier is mostly a qualification question, not a purchasing one. We have written up how to do it without losing a validation: switching human serum supplier.
Related
Not sure which variant your process needs?
Tell us the cell type and the application. We will recommend the variant, send the documentation, and put a free test sample in the post.
Request a quote or free sample
English 
Deutsch